Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...
The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report ...
The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...
While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.
Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.
The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...
On Friday, the FDA approved Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) ...
The Apple Watch Series 10 doesn't reinvent the wheel, but it does bring a series of genuinely helpful features.
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
Grab up to 60% off on the best water purifiers during the ongoing Amazon sale. Ensure clean, healthy drinking water with ...
Hundreds of Americans have jumped on a multi-state lawsuit alleging that the makers of Ozempic and Mounjaro caused ...
The Food and Drug Administration is expected to approve the first new type of drug for schizophrenia in decades. Called KarXT, the medicine appears to be effective, but its main advantage over current ...